يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"MESH: Down-Regulation/drug effects"', وقت الاستعلام: 1.37s تنقيح النتائج
  1. 1

    المساهمون: Mécanismes de tumorigenèse et thérapies ciblées, Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), FGMGP/USTHB, Université d'Algérie, Hôpital Rouïba [Algerie], Le centre hospitalier universitaire (CHU) Mustapha Pacha [Alger], Centre Hospitalo-Universitaire de Béni-Messous, CHU Nafissa Hamoud [Hussein Dey], University of Sciences and Technology Houari Boumediene [Alger] (USTHB), Institut de biologie de Lille - IBL (IBLI), Université de Lille, Sciences et Technologies-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Université de Lille, Droit et Santé-Centre National de la Recherche Scientifique (CNRS), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Centre National de la Recherche Scientifique (CNRS)-Université de Lille, Droit et Santé, They also thank the national agency of research development in health (ATRSS) which supported their project (code project: 03/06/01/10/011). They have also received support from the SIRIC ONCO Lille., The authors would like to gratefully thank all the participants involved in this study as well as the technical staff of the department of oncology (Rouiba Hospital) and Anatomic Pathology Service (Mustapha Pacha Hospital). They greatly thank Meroua BOUCHEMAL, Arezki CHEKAOUI and Dr. Kahina TOURI (USTHB, Algiers, Algeria) for all help and support of this work. Special thanks are extended to Dr. Mohamed Boudjelal and Science Edit for the Developing World for editing the English Language of the paper., Université des Sciences et de la Technologie Houari Boumediene = University of Sciences and Technology Houari Boumediene [Alger] (USTHB), Institut de biologie de Lille - UMS 3702 (IBL), Université de Lille-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Inflammopharmacology
    Inflammopharmacology, Springer Verlag, 2019, 27 (4), pp.685-700. ⟨10.1007/s10787-019-00566-9⟩
    Inflammopharmacology, 2019, 27 (4), pp.685-700. ⟨10.1007/s10787-019-00566-9⟩

  2. 2

    المساهمون: Laboratoire d'Epidémiologie Moléculaire et de Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Université de Tunis El Manar (UTM)-Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Université de Tunis El Manar (UTM), Temple University [Philadelphia], Pennsylvania Commonwealth System of Higher Education (PCSHE), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Centre Scientifique de Monaco (CSM), Laboratoire de Transmission, Contrôle et Immunobiologie des Infections - Laboratory of Transmission, Control and Immunobiology of Infection (LR11IPT02), Institut de Recherche sur le Cancer et le Vieillissement (IRCAN), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), This work was supported by the Tunisian Ministry of Higher Education and Scientific Research, the Institut Pasteur International Network (RIIP) and the University of Nice Sophia Antipolis, the French National Institute of Cancer (INCA) and the French Association for cancer research (ARC).

    المصدر: Molecular Carcinogenesis
    Molecular Carcinogenesis, Wiley, 2016, 56, pp.18-35. ⟨10.1002/mc.22470⟩

    مصطلحات موضوعية: Models, Molecular, Vascular Endothelial Growth Factor A, MESH: Vascular Endothelial Growth Factor A/genetics, MESH: Neovascularization, Pathologic/drug therapy, MESH: Colonic Neoplasms/drug therapy, MESH: Colonic Neoplasms/pathology, Apoptosis, MESH: MAP Kinase Signaling System/drug effects, MESH: Cell Proliferation/drug effects, Lebein, MESH: Colon/drug effects, MESH: Animals, MESH: Colon/metabolism, Neovascularization, Pathologic, MESH: Antineoplastic Agents/pharmacology, Integrin beta1, MESH: Chickens, MESH: Neovascularization, Pathologic/genetics, disintegrin, tumor growth, colon cancer, Colonic Neoplasms, MESH: Antineoplastic Agents/therapeutic use, MESH: Models, Molecular, MESH: Apoptosis/drug effects, MESH: Cell Line, Tumor, Colon, MAP Kinase Signaling System, MESH: Vascular Endothelial Growth Factor A/metabolism, Down-Regulation, Mice, Nude, Antineoplastic Agents, MESH: Viper Venoms/therapeutic use, [SDV.CAN]Life Sciences [q-bio]/Cancer, Viper Venoms, MESH: Cell Cycle Checkpoints/drug effects, MESH: Viper Venoms/pharmacology, Cell Line, Tumor, MESH: Down-Regulation/drug effects, MESH: Mice, Nude, Animals, Humans, MESH: Integrin beta1/metabolism, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Cell Proliferation, cellular effectors, MESH: Humans, Cell Cycle Checkpoints, MESH: Colonic Neoplasms/metabolism, MESH: Reactive Oxygen Species/metabolism, MESH: Colonic Neoplasms/genetics, MESH: Neovascularization, Pathologic/metabolism, MESH: Neovascularization, Pathologic/pathology, MESH: Colon/pathology, Reactive Oxygen Species, Chickens, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology